TABLE 1.
Compound | EC50 (μM) (SI)c |
THP-1 EC50 (μM) | |||
---|---|---|---|---|---|
Promastigotes |
Amastigotes |
||||
L. major | L. donovani | L. major | L. donovani | ||
VGP-106 | 21.55 ± 3.72 | 0.36 ± 0.09 | 13.07 ± 6.30 (15.8) | 0.86 ± 0.46 (240.2) | 206.54 ± 9.89 |
VGP-114 | 0.47 ± 0.04 | 0.61 ± 0.09 | 0.10 ± 0.03 (1000.6) | 0.85 ± 0.04 (117.7) | 100.06 ± 8.57 |
VGP-118 | 29.15 ± 5.73 | 0.65 ± 0.19 | 6.21 ± 1.02 (2.4) | 0.18 ± 0.03 (85.3) | 15.35 ± 3.99 |
VGP-130 | 0.50 ± 0.07 | 0.73 ± 0.11 | 0.09 ± 0.02 (903.7) | 2.02 ± 0.05 (40.3) | 81.34 ± 10.65 |
VGP-138 | 0.74 ± 0.19 | 2.11 ± 0.48 | 0.30 ± 0.16 (586.8) | 4.01 ± 0.43 (43.9) | 176.05 ± 20.75 |
VGP-146 | 0.21 ± 0.06 | 0.33 ± 0.07 | 0.10 ± 0.04 (156.1) | 0.42 ± 0.01 (37.2) | 15.61 ± 3.26 |
VGP-150 | 0.36 ± 0.11 | 0.77 ± 0.04 | 0.09 ± 0.03 (267) | 0.55 ± 0.16 (43.7) | 24.03 ± 5.42 |
VGP-162 | 0.40 ± 0.08 | 0.35 ± 0.02 | 0.37 ± 0.03 (29.6) | 1.00 ± 0.08 (11.0) | 10.97 ± 2.41 |
VGP-174 | 1.70 ± 0.01 | 0.34 ± 0.03 | 0.41 ± 0.05 (6.1) | 0.86 ± 0.03 (2.8) | 2.47 ± 0.05 |
VGP-182 | 2.51 ± 0.01 | 0.92 ± 0.2 | 0.42 ± 0.12 (11.2) | 0.52 ± 0.12 (9.1) | 4.71 ± 0.23 |
AmB | 0.32 ± 0.02 | 0.21 ± 0.01 | 0.24 ± 0.01 (59.7) | 0.28 ± 0.13 (51.1) | 14.32 ± 4.10 |
Miltefosine | 16.65 ± 1.23 | 6.60 ± 1.57 | 10.61 ± 0.89 (2.5) | 0.88 ± 0.14 (30.5) | 26.86 ± 3.08 |
Parasites were grown as described in Materials and Methods for 72 h at 28°C (promastigotes) or 37°C (intracellular amastigotes) in the presence of increasing concentrations of compounds. Data are means ± standard deviations of three independent determinations.
THP-1 cells were grown as described in Materials and Methods for 72 h at 37°C, in the presence of increasing concentrations of compounds. Cell viability was determined using an MTT-based assay. Amphotericin B (AmB) and miltefosine were used as the standard antileishmanial agents. Data are means ± standard deviations from three independent experiments.
Selectivity indexes (SI) were calculated by dividing the EC50 for THP-1 by that for intracellular amastigotes.